Atom Investors LP Esperion Therapeutics, Inc. Transaction History

Atom Investors LP

  • $906 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022
BUY
$5.45 - $8.13 $663,384 - $989,599
121,722 New
121,722 $816,000
Q1 2020

May 15, 2020
SELL
$27.44 - $73.84 $216,830 - $583,483
-7,902 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$35.4 - $59.82 $279,730 - $472,697
7,902 New
7,902 $471,000

Others Institutions Holding ESPR

# of Institutions
209
Shares Held
129M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $140M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email